EDITORIAL
Pharmacology and toxicology
Clozapine, agranulocytosis, and benign ethnic neutropenia
Correspondence to:
Correspondence to:
Dr S Rajagopal
South London and Maudsley NHS Trust, Adamson Centre for Mental Health, St Thomas’s Hospital, London SE1 7EH, UK; Sundararajan.Rajagopal@slam.nhs.uk
Current knowledge and clinical implications
Keywords: clozapine; agranulocytosis; neutropenia; ethnic; benign
| The first 150 words of the full text of this article appear below. |
Clozapine is an atypical antipsychotic that is effective in treatment resistant schizophrenia.1 The National Institute for Health and Clinical Excellence (NICE) guidelines for schizophrenia specify that "in individuals with evidence of treatment resistant schizophrenia, clozapine should be introduced at the earliest opportunity".2
A severe adverse effect of clozapine that limits its more widespread use is agranulocytosis. Patients who are taking clozapine need to have their full blood counts (FBC) monitored regularly, and if the total white cell and/or neutrophil counts indicate agranulocytosis, clozapine prescription must be terminated. Among certain ethnic groups, a significant proportion of people have a low baseline neutrophil count. This is called benign ethnic neutropenia (BEN). This editorial looks at the important issues associated with agranulocytosis and BEN in patients receiving clozapine.
Agranulocytosis occurs in about 1% of patients taking clozapine.3,4 Neutropenia is seen in about 3%.4 The risk of both agranulocytosis and neutropenia
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
-
Ghaznavi, S., Nakic, M., Rao, P., Hu, J., Brewer, J. A., Hannestad, J., Bhagwagar, Z.
(2008). Rechallenging With Clozapine Following Neutropenia: Treatment Options for Refractory Schizophrenia. Am. J. Psychiatry
165: 813-818
[Full Text] -
Kelly, D. L., Kreyenbuhl, J., Dixon, L., Love, R. C., Medoff, D., Conley, R. R.
(2007). Clozapine Underutilization and Discontinuation in African Americans Due to Leucopenia. Schizophr Bull
33: 1221-1224
[Abstract] [Full Text]
eLetters:
Read all eLetters
- Benign neurotropenia during clozapine treatment
- David Esposito, et al.
- Postgrad Med J Online, 14 Sep 2005 [Full text]
- Clozapine, agranulocytosis, and benign ethnic neutropenia
- David Esposito, et al.
- Postgrad Med J Online, 30 Sep 2005 [Full text]
- Full Text
- Full Text (PDF)
- Submit a response
- Read responses to this article
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
-
Immunology (including allergy)
-
Psychotic disorders (incl schizophrenia)
-
Genetics
-
Drugs: psychiatry
- Epidemiology
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
